Mark Talamonti to Pancreas
This is a "connection" page, showing publications Mark Talamonti has written about Pancreas.
Connection Strength
0.536
-
Does minimally invasive surgery have a different impact on recurrence and overall survival in patients with pancreatic head versus body/tail cancer? J Surg Oncol. 2023 Jul; 128(1):23-32.
Score: 0.202
-
Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement. Ann Surg Oncol. 2009 Jul; 16(7):1727-33.
Score: 0.077
-
Borderline resectable pancreatic cancer: a new classification for an old challenge. Ann Surg Oncol. 2006 Aug; 13(8):1019-20.
Score: 0.063
-
Pancreatic stellate cells (PSCs) express cyclooxygenase-2 (COX-2) and pancreatic cancer stimulates COX-2 in PSCs. Mol Cancer. 2005 Aug 05; 4:27.
Score: 0.059
-
Pancreatic cancer stimulates pancreatic stellate cell proliferation and TIMP-1 production through the MAP kinase pathway. Biochem Biophys Res Commun. 2004 Oct 29; 323(4):1241-5.
Score: 0.056
-
Atypical acinar cell foci in human pancreas. Morphological and morphometric analysis. Int J Pancreatol. 1997 Oct; 22(2):127-30.
Score: 0.035
-
Concurrent PEDF deficiency and Kras mutation induce invasive pancreatic cancer and adipose-rich stroma in mice. Gut. 2012 Oct; 61(10):1454-64.
Score: 0.023
-
Mucinous nonneoplastic cyst of the pancreas: apomucin phenotype distinguishes this entity from intraductal papillary mucinous neoplasm. Hum Pathol. 2010 Apr; 41(4):513-21.
Score: 0.020